Cincinnati, United States, December 28: A new study has revealed that bortezomib, a drug used in the treatment of cancerdefine, can also stop the body from discarding a transplanted organ.
Traditionally bortezomib has been used to cure multiple myeloma, which affects the plasmadefine of white blood cells. The present research has divulged that Bortezomib aims B-lymphocytes, the WBCs that manufacture antibodies, and thwarts the immune systemdefine's antibodies from attacking transplanted organs.